Cargando…
Gene Expression and Methylation Analysis in Melanomas and Melanocytes From the Same Patient: Loss of NPM2 Expression Is a Potential Immunohistochemical Marker for Melanoma
DNA methylation is considered the primary epigenetic mechanism underlying the development of malignant melanoma. Since DNA methylation can be influenced by environmental factors, it is preferable to compare cancer and normal cells from the same patient. In order to compare the methylation status in...
Autores principales: | Fujiwara, Susumu, Nagai, Hiroshi, Jimbo, Haruki, Jimbo, Naoe, Tanaka, Tomoyo, Inoie, Masukazu, Nishigori, Chikako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348333/ https://www.ncbi.nlm.nih.gov/pubmed/30719424 http://dx.doi.org/10.3389/fonc.2018.00675 |
Ejemplares similares
-
Cultured epidermal autografts for treatment of stable vitiligo: Quantitative analysis of color matching with surrounding normally pigmented skin
por: Toriyama, Kazuhiro, et al.
Publicado: (2021) -
CKS1 expression in melanocytic nevi and melanoma
por: Brożyna, Anna A., et al.
Publicado: (2017) -
Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib
por: Otsuka, Haruhiko, et al.
Publicado: (2022) -
PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas)
por: Medic, Sandra, et al.
Publicado: (2010) -
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions
por: Parente, Paola, et al.
Publicado: (2008)